Онкология
2237 статей · 70 журналов
Динамика публикаций
Журналы подкатегории (70)
- Blood Neoplasia · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- European Journal of Surgical Oncology · Elsevier (85)
- Cancer Treatment and Research Communications · Elsevier (83)
- The Lancet Oncology · Elsevier (83)
- Brachytherapy · Elsevier (81)
- Cancer Epidemiology · Elsevier (80)
- Journal of Thoracic Oncology · Elsevier (80)
- International Journal of Gynecological Cancer · Elsevier (79)
- EJC Skin Cancer · Elsevier (76)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Lung Cancer · Elsevier (68)
- Critical Reviews in Oncology/Hematology · Elsevier (66)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (62)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (58)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (58)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (53)
- The Journal of Liquid Biopsy · Elsevier (52)
- Leukemia Research · Elsevier (51)
- Cancer Letters · Elsevier (50)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (39)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (32)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (20)
- Intelligent Oncology · Elsevier (18)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Exercise against cancer: recent advances and open questions
- Accelerated aging and early-onset colorectal cancer
- Comparison of novel salvage therapies for BCG-unresponsive NMIBC against gemcitabine/docetaxel: A reconstructed individual patient data analysis
- Nanoparticle delivery of phytochemicals and dietary factors for epigenetic modulation in prostate cancer
- Trends at 50: a mission that matters
- PARP inhibitor–based combinations in first-line metastatic castration-resistant prostate cancer: A meta-analysis
- FOXP2/FABP4 axis promotes bladder cancer aggressiveness by driving lipid metabolic reprogramming to activate FAK/Src signaling
- Liver transplant team involvement in level III and IV renal tumor thrombectomy: Perioperative and oncologic outcomes
- Nonsurgical UGN-102 for recurrent LG-IR-NMIBC: Pooled efficacy and safety from phase 2 and 3 trials
- A roadmap for quantifying metabolism in patients with cancer
- Navigating clinical decisions through cancer cartography
- Advisory Board and Contents
- From fixed antibody–drug conjugates to programmable therapeutics
- Lkb1 loss links dietary lipids to cancer cachexia
- Not ‘cold’ but conditional: emerging principles of immunotherapy in colorectal cancer
- Cancer cell plasticity: new insights from developmental programs
- Evolution of mantle cell lymphoma therapy: advancing frontline precision
- Neuron–tumor communication in solid tumors: from bona fide synapses to pseudo-synaptic neural interfaces
- Immune cell metabolic reprogramming mediates ICI therapy resistance
- Precision targeting of stromal states in pancreatic cancer: a clinical perspective
- Prostate cancer: evading immunity, inspiring therapy
- Subscription & copyright page
- Acral melanoma: a unique subtype requiring unique solutions
- Glioma–neuron interactions: from basics to therapy
- Immune evasion in cancer dormancy and metastatic reactivation
- PiRNA-Hsap_1847317 may serve as a novel biomarker of PD-1 inhibitor resistance in patients with advanced non-small cell lung cancer
- The CARM1–YIPF2 axis drives breast cancer progression and predicts poor prognosis
- A multivariate plasma biomarker model for glioblastoma exclusion: a retrospective case-control study
- IGF binding proteins: emerging endocrine mediators of cancer-associated muscle wasting
- FOLFIRINOX vs. gemcitabine/nab-paclitaxel for metastatic pancreatic cancer: A real-world study